Uchida Yoshikazu, Holleran Walter M, Elias Peter M
Department of Dermatology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
J Dermatol Sci. 2008 Jul;51(1):37-43. doi: 10.1016/j.jdermsci.2008.02.007. Epub 2008 Apr 8.
Ceramides (Cer) in the stratum corneum are essential for epidermal permeability barrier function. Thus, topical Cer replacement therapy has been employed to improve barrier function in clinical situations associated with Cer deficiency, e.g., atopic dermatitis. Because of the disadvantages of both natural- and skin identical-Cer (central nervous system origins and cost, respectively), synthetic chemical mimics, or pseudoceramides (pseudo-Cer), have been utilized as Cer substitutes. Whereas increased levels of intracellular Cer trigger cell growth inhibition and apoptosis, Cer levels are maintained by metabolic/catabolic pathways protecting cells from Cer-induced apoptosis. However, since the metabolic fates of each pseudo-Cer remain unknown, their widespread deployment in topical agents has raised concern about potential toxicities.
We compared the effects of two chemically unrelated commercially available pseudo-Cer to exogenous cell-permeant (C2)- or natural (C18)-Cer on cell growth and apoptosis thresholds in cultured human keratinocytes (CHK).
Cell growth and cell toxicity of CHK exposed to either C2-Cer or pseudo-Cer were assessed by MTT and lactate dehydrogenase release assays. Mitochondrial membrane potential, an indicator of apoptosis, was measured using membrane permeabilized semi-intact keratinocytes exposed C2-Cer, natural-Cer or pseudo-Cer.
While the cell-permeant-Cer inhibits keratinocyte growth and increases cell toxicity, neither of the pseudo-Cer showed these effects. Decreased mitochondrial membrane potential occurred in CHK incubated with cell-permeant- and natural-Cer, but not pseudo-Cer.
Taken together with preclinical safety studies of these pseudo-Cer and their widespread use over the counter without evidence of toxicity, these studies provide further assurance about the safety of these pseudo-Cer for topical use.
角质层中的神经酰胺(Cer)对于表皮渗透屏障功能至关重要。因此,局部应用神经酰胺替代疗法已被用于改善与神经酰胺缺乏相关的临床情况,例如特应性皮炎。由于天然神经酰胺和皮肤等同神经酰胺分别存在中枢神经系统来源和成本高的缺点,合成化学模拟物或假神经酰胺(pseudo-Cer)已被用作神经酰胺替代品。虽然细胞内神经酰胺水平升高会触发细胞生长抑制和凋亡,但神经酰胺水平通过代谢/分解代谢途径维持,保护细胞免受神经酰胺诱导的凋亡。然而,由于每种假神经酰胺的代谢命运尚不清楚,它们在局部用药中的广泛应用引发了对潜在毒性的担忧。
我们比较了两种化学结构不相关的市售假神经酰胺与外源性细胞渗透性(C2)-或天然(C18)-神经酰胺对培养的人角质形成细胞(CHK)细胞生长和凋亡阈值的影响。
通过MTT和乳酸脱氢酶释放试验评估暴露于C2-神经酰胺或假神经酰胺的CHK的细胞生长和细胞毒性。使用暴露于C2-神经酰胺、天然神经酰胺或假神经酰胺的膜通透化半完整角质形成细胞测量凋亡指标线粒体膜电位。
虽然细胞渗透性神经酰胺抑制角质形成细胞生长并增加细胞毒性,但两种假神经酰胺均未显示出这些作用。与细胞渗透性和天然神经酰胺孵育的CHK中线粒体膜电位降低,但与假神经酰胺孵育的CHK中未出现这种情况。
结合这些假神经酰胺的临床前安全性研究以及它们在非处方中的广泛使用且无毒性证据,这些研究进一步证明了这些假神经酰胺局部使用的安全性。